African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.

Since its initiation in 1995, the African Program for Onchocerciasis Control (APOC) has had a substantial impact on the prevalence and burden of onchocerciasis through annual ivermectin mass treatment. Ivermectin is a broad-spectrum anti-parasitic agent that also has an impact on other co-endemic pa...

Full description

Bibliographic Details
Main Authors:	Stanimira P Krotneva, Luc E Coffeng, Mounkaila Noma, Honorat G M Zouré, Lalle Bakoné, Uche V Amazigo, Sake J de Vlas, Wilma A Stolk
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4581698?pdf=render

Similar Items

African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
by: Luc E Coffeng, et al.
Published: (2013-01-01)

African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights.
by: Luc E Coffeng, et al.
Published: (2014-06-01)

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
by: Luc E Coffeng, et al.
Published: (2014-01-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
by: Elhassan Elizabeth, et al.
Published: (2011-07-01)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.
by: Anneke S de Vos, et al.
Published: (2021-05-01)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis.
by: Anneke S de Vos, et al.
Published: (2018-10-01)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2021-07-01)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
by: Mary Amuyunzu-Nyamongo, et al.
Published: (2011-05-01)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
by: Natalie V. S. Vinkeles Melchers, et al.
Published: (2018-09-01)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
by: Natalie V S Vinkeles Melchers, et al.
Published: (2021-06-01)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
by: Yvonne L Lont, et al.
Published: (2017-01-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

Molecular epidemiology of emerging ivermectin resistance in onchocerciasis
by: Osei-Atweneboana, Mike Yaw, 1966-
Published: (2008)

Managing the Fight against Onchocerciasis in Africa: APOC Experience.
by: Grace Fobi, et al.
Published: (2015-05-01)

Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
by: Méba Banla, et al.
Published: (2014-01-01)

Importance of ivermectin to human onchocerciasis: past, present, and the future
by: Cupp EW, et al.
Published: (2011-05-01)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018-04-01)

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
by: Guy-Roger Kamga, et al.
Published: (2016-11-01)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021-03-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

The need for evidence-based strategies and tools for onchocerciasis elimination in Africa
by: Yankum Dadzie, et al.
Published: (2019-07-01)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017-08-01)

Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae.
by: Luc E Coffeng, et al.
Published: (2013-01-01)

Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)
by: E.O. Omondi, et al.
Published: (2018-01-01)

Immunity in onchocerciasis after ivermectin prophylaxis : studies with Onchocerca ochengi in cattle
by: Njongmeta, Leo Moh
Published: (2002)

The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA).
by: Honorat Gustave Marie Zouré, et al.
Published: (2011-06-01)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
by: Moses N. Katabarwa, et al.
Published: (2013-01-01)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Onchocerciasis control in Ghana (1974–2016)
by: Nana-Kwadwo Biritwum, et al.
Published: (2021-01-01)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
by: Natalie V. S. Vinkeles Melchers, et al.
Published: (2020-06-01)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
by: Proaño Roberto, et al.
Published: (2007-05-01)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014-05-01)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
by: Armelle Forrer, et al.
Published: (2021-01-01)

Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control
by: Sake J. de Vlas, et al.
Published: (2021-02-01)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
by: Wondafrash Mekite, et al.
Published: (2010-06-01)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.
by: Abdi Samuel, et al.
Published: (2016-01-01)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
by: Olaitan Olamide Omitola, et al.
Published: (2021-04-01)

Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes
by: Yankum Dadzie, et al.
Published: (2018-07-01)

Cannot write session to /tmp/vufind_sessions/sess_8essqcqamsjsq1tgn0hfgqaudo